• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查。谁需要做巴氏试验?多久做一次?

Cervical cancer screening. Who needs a Pap test? How often?

作者信息

Benedet J L, Murphy K J

出版信息

Postgrad Med. 1985 Dec;78(8):69-71, 74-6, 78-9. doi: 10.1080/00325481.1985.11699220.

DOI:10.1080/00325481.1985.11699220
PMID:4070103
Abstract

Cancer of the cervix and its preinvasive forms are ideally suited to control by means of cytologic screening programs. Ample evidence shows that widespread use of such programs markedly reduces both the incidence and mortality of clinically invasive carcinoma of the cervix. Thus, physicians should encourage female patients to participate in a cervical cytologic screening program. In addition, family practitioners and internists, when seeing female patients for nongynecologic problems, should not miss the opportunity to obtain a Pap smear whenever appropriate.

摘要

宫颈癌及其癌前病变非常适合通过细胞学筛查项目进行控制。大量证据表明,广泛开展此类项目可显著降低宫颈癌临床浸润癌的发病率和死亡率。因此,医生应鼓励女性患者参与宫颈细胞学筛查项目。此外,家庭医生和内科医生在诊治非妇科问题的女性患者时,应在适当的时候不失时机地进行巴氏涂片检查。

相似文献

1
Cervical cancer screening. Who needs a Pap test? How often?宫颈癌筛查。谁需要做巴氏试验?多久做一次?
Postgrad Med. 1985 Dec;78(8):69-71, 74-6, 78-9. doi: 10.1080/00325481.1985.11699220.
2
Carcinoma of the cervix in a pregnant woman with negative Pap smears and colposcopic examination.
Acta Obstet Gynecol Scand. 1990;69(7-8):657-8. doi: 10.3109/00016349009028715.
3
Present standards for cervical cancer screening.宫颈癌筛查的现行标准。
Curr Opin Oncol. 2002 Sep;14(5):505-11. doi: 10.1097/00001622-200209000-00006.
4
The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.挪威1992 - 2000年宫颈癌筛查项目:巴氏涂片覆盖率及宫颈癌发病率的变化
J Med Screen. 2002;9(2):86-91. doi: 10.1136/jms.9.2.86.
5
Cervical cancer screening. Past success and future challenge.宫颈癌筛查。过去的成就与未来的挑战。
Prim Care. 1992 Sep;19(3):589-606.
6
Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.巴氏涂片检查:我们能否让一项良好的检查变得更好?从业者面临的技术与解读挑战
J Womens Health Gend Based Med. 1999 May;8(4):469-76. doi: 10.1089/jwh.1.1999.8.469.
7
[Cytological history of 148 women presenting with invasive cervical cancer].[148例浸润性宫颈癌女性患者的细胞学病史]
Gynecol Obstet Fertil. 2002 Mar;30(3):210-7. doi: 10.1016/s1297-9589(02)00297-7.
8
The Pap smear revisited. Controversies and recent developments.巴氏涂片检查再探讨。争议与近期进展。
Postgrad Med. 1984 Nov 1;76(6):36-40, 42-3, 46. doi: 10.1080/00325481.1984.11698775.
9
Workup of the abnormal Pap test.巴氏试验异常的检查
Clin Cornerstone. 2000;3(1):12-24. doi: 10.1016/s1098-3597(00)90018-8.
10
Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.筛查频率和组织学类型影响宫颈癌筛查效果:一项全国性队列研究。
Taiwan J Obstet Gynecol. 2017 Aug;56(4):442-448. doi: 10.1016/j.tjog.2017.01.010.

引用本文的文献

1
[Knowledge, attitude and behavior of Tunisian women apropos of gynecological cancers].[突尼斯女性对妇科癌症的认知、态度及行为]
Soz Praventivmed. 1994;39(5):280-6. doi: 10.1007/BF01298839.